Contemporary Trends and Predictors Associated with Adverse Pathological Upstaging Among Non-Metastatic Localized Clinical T2 Muscle-Invasive Bladder Cancers Undergoing Radical Cystectomy: Outcomes from a Single Tertiary Centre in the United Kingdom
Authors:
- Francesco Del GiudiceFrancesco Del Giudice
- Yasmin Abu-GhanemYAYasmin Abu-Ghanem
- Rajesh NairRNRajesh Nair
- Elsie MensahEMElsie Mensah
- Jonathan KamJKJonathan Kam
- Youssef IbrahimYIYoussef Ibrahim
- Mohamed GadMohamed Gad
- Kathryn ChattertonKCKathryn Chatterton
- Suzanne AmerySASuzanne Amery
- Romerr AlaoRARomerr Alao
- Ben ChallacombeBCBen Challacombe
- Mohammed HegazyMHMohammed Hegazy
Open Access
Abstract
Introduction: Radical cystectomy (RC) is the gold standard for urothelial cT2-4a, N0, M0 muscle-invasive bladder cancer (MIBC). However, bladder-sparing strategies (BSS) such as Trimodality Therapy (TMT) have emerged as alternative treatments for a select group of localized muscle-confined (cT2) urothelial bladder cancers. Accordingly, reliable preoperative staging and a reliable risk factor assessment linked to pathological upstaging play a key role in adequate counselling and patient selection for BSS. Patients and Methods: cT2 MIBC patients undergoing RC at our institution from 2014 to 2024 were reviewed. Preoperative staging modalities, demographics, and tumour and patient characteristics were assessed. Multivariable logistic regression was applied to explore the relative effect of confounders on any pathological upstaging from robot-assisted or open RC specimens. Subgroup analysis according to the local upstaging (>pT2) or nodal dissemination (pN+) was also performed. Results: N = 275 RCs were included (73.5% males, 26.5% females). Upstaging was documented in n = 141 (51%) cases. Of these, n = 125 (45.5%) were upstaged locally (>pT2) and n = 35 (23%) yielded pN+ disease. Preoperative parameters like gender, the number of TURBTs, previous BCG exposure, and concomitant CIS did not significantly influence the risk of any kind of upstaging (p > 0.05). At multivariable analysis, neoadjuvant chemotherapy (NAC) and multi-disciplinary team (MDT) discussion were found protective (odds ratio [OR]: 0.4, 95%CI 0.2–0.7, p = 0.001 and OR: 0.51, 95%CI 0.2–0.9, p = 0.01). Preoperative FDG-PET assessment yielded higher risk for later pN upstaging (OR: 1.8, 95%CI 1–3, p = 0.05). HG/G3 features at TURBT along with mixed/pure histology variants in RC specimens were the most relevant independent predictors for both any and pT upstaging (OR: 4.3, 95%CI 1–34, p = 0.04 and OR: 2.3, 95%CI 1.1–4.6, p = 0.02 for any upstaging and OR: 5.6, 95%CI 1.3–36, p = 0.02 and OR: 2.5, 95%CI 1.3–5, p = 0.01 for pT upstaging, respectively). Conclusions: In this study, over half of the patients undergoing RC for cT2 were upstaged at the final pathology. Therefore, adequate counselling and examining the non-conventional criteria for prognosis is mandatory in the contemporary era of bladder-preservation strategies.Keywords
This publication has 40 references indexed in Scilit:
- Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons’ perspectives and recommendations ten years after its implementationEuropean Journal of Surgical Oncology, 2024
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical CystectomyClinical Genitourinary Cancer, 2023
- Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancerWorld Journal of Urology, 2023
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Bladder Cancer2021
- Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experienceWorld Journal of Urology, 2019
- Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyEuropean Urology, 2017
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent TrendsEuropean Urology, 2017
- Economic Burden of Bladder Cancer Across the European UnionEuropean Urology, 2016
- Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancerWorld Journal of Urology, 2013